Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00715338 · ClinicalTrials.gov registry record

Effects of Oxygen on Lung Tissue During Anesthesia

A clinical trial, sponsored by Vanderbilt University.

Terminated
Registry status
10
Enrollment target

NCT00715338: Clinical Trial study, sponsored by Vanderbilt University.

NCT00715338 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00715338 was terminated before completion, sponsored by Vanderbilt University.

TERMINATED
Registry status
10 participants
Enrollment target

Study Summary

Collect exhaled breath condensates from patients scheduled for a routine surgical procedure before, during, and after surgery for measurements of IsoFs Draw blood from patients scheduled for a routine surgical procedure before, during, and after surgery for measurements of serum thrombomodulin.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2008-06
Est. Completion 2008-09
Vanderbilt University

430 total trials

Why NCT00715338 stopped before completion

NCT00715338 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00715338 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00715338 about?

NCT00715338 is a clinical study titled "Effects of Oxygen on Lung Tissue During Anesthesia". Collect exhaled breath condensates from patients scheduled for a routine surgical procedure before, during, and after surgery for measurements of IsoFs Draw blood from patients scheduled for a routine surgical procedure before, during, and after surgery for measurements of serum thrombomodulin.

What is the current status of trial NCT00715338?

This trial is currently terminated. The enrollment target is 10 participants. The study started on 2008-06. Estimated completion is 2008-09.

Who is sponsoring clinical trial NCT00715338?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00715338, the US trial registry maintained by the National Library of Medicine. NCT00715338 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.